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Background: Previous studies have shown that poor cognition and low body mass index were associated with
increased mortality. But few studies have investigated the association between cognition and mortality across the
entire cognitive spectrum while adjusting for BMI. The objective of this study is to examine the associations
between cognitive function, BMI and 7-year mortality in a rural elderly Chinese cohort.
Methods: A prospective cohort of 2,000 Chinese age 65 and over from four rural counties in China were followed
for 7-years. Cognitive function, BMI and other covariate information were obtained at baseline. Cox’s proportional
hazard models were used to determine the effects of cognitive function and BMI on mortality risk.
Results: Of participants enrolled, 473 (23.7%) died during follow-up. Both lower cognitive function (HR = 1.48, p = 0.0049)
and lower BMI (HR = 1.6, p < 0.0001) were independently associated with increased mortality risk compared to individuals
with average cognitive function and normal weight. Higher cognitive function was associated with lower mortality risk
(HR = 0.69, p = 0.0312). We found no significant difference in mortality risk between overweight/obese participants and
those with normal weight.
Conclusions: Cognitive function and BMI were independent predictors of mortality risk. Intervention strategies for
increasing cognitive function and maintaining adequate BMI may be important in reducing morality risk in the elderly
population.Background
Increased mortality risk in the elderly population has
been shown to be associated with a number of factors
including older age, male gender, cardiovascular disease
(CVD) and other illnesses [1]. While many previous studies
have examined the association between body mass index
(BMI) and mortality and between cognitive function and
mortality, few have data with both cognitive and BMI mea-
sures to determine the combined effects from cognition
and BMI on mortality risk. In particular, previous research
has found that individuals with lower cognitive function
were at increased mortality risk which was often attributed
to cognitive impairment, dementia and Alzheimer’s disease
[2,3]. Few studies, however, have investigated the associ-
ation between cognition and mortality across the entire* Correspondence: sgao@iupui.edu
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unless otherwise stated.cognitive spectrum. Theoretically, high cognitive function
can indicate larger cognitive reserve that may allow indi-
viduals with larger reserves to maintain normal functions
despite of similar brain disease pathology as those with
smaller reserves [4]. To the best of our knowledge, no
study to date has addressed the risk of mortality in older
adults with high cognitive function.
Similar to the relationship between low cognition and
mortality, prior studies have also shown that low body mass
index (BMI) is associated with increased mortality [5].
However, the precise relationship between BMI and mortal-
ity remains uncertain. A study in one and half million white
adults found a U-shaped relationship between BMI and
mortality such that individuals at both ends of the BMI
scale, i.e. those underweight and those overweight or obese
had increased mortality risk when compared to those with
normal weight [6]. However, a recent meta-analysis of 97
studies reported lower mortality among overweight and
moderately obese individuals relative to those with normal. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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terintuitive finding of lower risk associated with higher BMI
in this meta-analysis and other studies [8] is that a high
BMI may provide physiological reserve thus conferring pro-
tection against potential disease or illnesses [9,10].
Thus, BMI and cognition may have similar relationships
to survival in the elderly population as both may indicate
levels of reserve, one physiological and the other cognitive.
The objectives of this study are to examine the associa-
tions between cognitive function, BMI and 7-year mortal-
ity in a rural elderly Chinese cohort.
Methods
Study population
Two thousand Chinese age 65 and over from four counties
in China were enrolled in this study between December
2003 and May 2005. Two counties were from Sichuan
province in southwestern China and two counties were
from Shandong province in eastern China. For each village
included in the study, the Chinese investigators and a team
of interviewers who were employees of provincial and
county Center for Disease Control traveled to the area,
established a temporary headquarter and conducted a com-
plete census of residents over age 65 in the area. They en-
rolled eligible residents by going door-to-door, obtaining
informed consent before conducting interviews and collect-
ing biological samples. There were no refusals. Since there
were outreach activities by employees from the county
offices of the Chinese Center for Disease Control to pre-
pare each community for the surveys, no refusal was not
surprising and it was not unusual for studies conducted in
rural China, as reported in our pilot study [11] and a large
dementia prevalence study [12]. However, a few subjects
with hearing problems were not enrolled. The study was
approved by Indiana University Institutional Review Board
and the Institute for Environmental Health and Related
Safety, Chinese Center for Disease Control and Preven-
tion. Details of the study were described previously [13].
Endpoints
Cognitive assessment was conducted at baseline enroll-
ment. Two follow-up evaluations were conducted at 2.5
and 7 years after the baseline assessment. For participants
who had died, interviews were conducted with a close rela-
tive to obtain date of death. Nine participants had died but
their relatives were not able to provide death date; thus we
used the median time point between their last evaluation
time and date of the follow-up evaluation as an estimate
for date of death. For surviving participants, censoring time
was defined as the last time they were evaluated.
Cognitive assessment
Cognitive assessment was conducted in face-to-face inter-
views using six cognitive tests: the Community ScreeningInstrument for Dementia (CSID), CERAD 10-word list
learning, word-list recall [14], IU Story Recall, Animal Flu-
ency test [15], and IU Token test. The CSID was devel-
oped as a screening tool for dementia in populations with
various cultural backgrounds and literacy levels. Details of
the instrument have been published elsewhere [16]. In this
analysis, a composite cognitive z-score was derived by
using the average of standardized scores of the six cogni-
tive tests.
BMI measures
Participants’ height in meters and weight in kilograms were
measured during the baseline interview. Body Mass Index
(BMI) was derived weight in kilograms divided by height in
meters squared.
Collection of other risk factors
Other risk factors collected during the baseline interview
include age, gender, whether the participant attended school
and years of schooling, marital status (married, widowed or
other), household composition (living with spouse, living
with children, living with spouse and children, or other),
alcohol consumption and smoking history (yes or no),
history of cancer, Parkinson’s disease, diabetes, hyperten-
sion, stroke, heart attack, head injury and bone fracture.
Participants’ blood pressure (2 times) was also measured
during the interview. The average of the two blood pres-
sure measures were used in our analyses. Blood spots on
filter paper were collected from all study participants at
the end of the interview. Apolipoprotein E (APOE) geno-
type was determined by eluting DNA from a dried blood
spot [17] followed by Hhal digestAPOEion of amplified
products [18].
Statistical analysis
In order to capture potential nonlinear association between
baseline cognitive function and mortality, we divided the
study population into quintiles according to baseline cogni-
tive z-score levels. BMI was modeled using the World
Health Organization criteria into four groups: underweight
(BMI < 18.5), normal weight (18.5 ≤ BMI < 25), overweight
(25 ≤ BMI < 30), and obese (BMI ≥ 30) [19]. The following
variables were considered to be potential confounders pos-
sibly related to mortality: age at baseline, gender, education
(whether the participant attended school), marital status,
household composition, alcohol consumption and smoking
history, systolic and diastolic blood pressure measures,
APOE genotype (ε4 carriers vs. non-carriers) and history of
comorbidities, such as cancer, Parkinson’s disease, diabetes,
hypertension, stroke, heart attack, head injury and fracture.
Analysis of variance models (ANOVA) were used to com-
pare differences in continuous variables, and chi-square
tests were used to compare differences in categorical vari-
ables across the five quintile groups defined by cognitive
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survival probabilities for the cohort stratified by cognitive
quintile and BMI groups, respectively. Univariate Cox’s
proportional hazard model was used to examine the asso-
ciation between each covariate and mortality risk. Multi-
variate Cox’s proportional hazard model was used to
explore the association between cognitive scores, BMI and
mortality adjusting for significant covariates identified in
univariate models.
Results
Of the 2000 participants enrolled at baseline, 144 died
prior to the 2.5 year follow-up evaluation and 329 partici-
pants died between the 2.5 year and the 7 year follow-up
evaluations. In Table 1, we present baseline characteristics
of study participants by cognitive quintile groups. Age,
gender, education, marital status, household composition,
smoking, consuming alcohol, BMI, history of hypertension
and heart attack were significantly different among cog-
nitive quintile groups. In particular, participants in the
lowest cognitive quintile group were more likely to be
underweight and those with the highest cognitive scores
were more likely to be overweight or obese.
Kaplan-Meier survival estimates by cognitive quintile
groups were presented in Figure 1. There were signifi-
cant differences in survival probabilities among the five
cognitive quintile groups (p < 0.0001). Participants with
the lowest cognitive scores had the lowest survival prob-
ability and those with the highest cognitive scores had the
best survival probability while quintile groups 2, 3 and 4
showed similar survival probabilities. Kaplan-Meier sur-
vival estimates by BMI groups were presented in Figure 2.
Participants in the underweight group had the lowest sur-
vival probability while the obese group seems to have
higher survival, although there were fewer deaths in that
group making the survival curve for that group unstable.
The overweight participants showed similar survival prob-
ability to those with normal weight.
In univariate Cox’s models, we found that increasing
age, male gender, being widowed, living with children,
smokers, drinkers, lower BMI, history of Parkinson’s dis-
ease, diabetes, stroke, or lower cognitive function were
each significantly associated with lower survival probabil-
ity. APOE ε4 carrier status was not associated with mortal-
ity risk in univariate Cox’s model (HR = 1.01, p = 0.9296).
In Table 2 we present the multivariate Cox’s model with
both cognitive quintile groups and BMI groups. Partici-
pants with the lowest cognitive scores, i.e. those in the 1st
quintile group, had 47.5% increase in mortality compared
to those with average cognitive score (3rd quintile group).
Participants with the highest cognitive scores, on the other
hand, had a 31.4% reduction in hazard rate of death. Par-
ticipants who were underweight at baseline had increased
mortality risk (HR = 1.6, p < 0.0001) compared to thosewith normal weight. Individuals in the overweight group
or the obese group were not significantly different in haz-
ard rate from those in the normal weight group.
In order to determine whether the increased mortality
for the underweight participants or those with poor
cognition is due to severe illness, we repeated the multi-
variate Cox’s models excluding individuals who died
within one year of their baseline evaluation. The effect
of underweight was attenuated, but remained significant
(HR = 1.465, p < 0.0028) compared to those with normal
weight. However, there is no longer an increased risk from
the poor cognition group. Given results obtained in the en-
tire sample where the poor cognition group had increased
mortality risk, it seems to indicate that those in the lowest
cognitive quintile were more likely to die within one year
of the baseline. The protective effect in the highest cogni-
tive score quintile group remained significant as seen in
the entire cohort. There is no significant interaction be-
tween cognitive function and BMI on mortality in the en-
tire sample (p = 0.3276) or the sub-sample (n = 0.5874).
Discussion
In this rural elderly Chinese cohort followed for seven
years, we found that both lower cognitive function and
lower BMI are independently associated with increased
mortality risk compared to individuals with average cogni-
tive function and normal weight. In addition, we found that
higher cognitive function is associated with lower mortality
risk. At the same time, we found no significant difference in
mortality risk between overweight/obese participants and
those with normal weight.
Previous studies have reported increased mortality risk
of individuals with poor cognitive function and have at-
tributed the increased risk to cognitive impairment and
dementia [3,20-23]. When we excluded participants who
died within the first year of baseline, poor cognition was
no longer significantly associated with increased mortal-
ity, suggesting that terminal illnesses may be a cause for
poor cognition [2]. However, few studies have separately
examined mortality risk in individuals with higher than
average cognitive scores. Our result of lower mortality
risk in individuals from the top cognitive quintile group
compared to those with average cognitive scores sug-
gests a potential protective mechanism of high cognitive
function in the absence of disease pathology. This pro-
tective effect could result from more years of formal
education, a more intellectually stimulating job, life-long
pursuit of leisure activities with cognitive benefit, or
healthier lifestyles [24]. In our study, individuals with the
highest cognitive function also had the highest propor-
tion of schooling, although education itself was not an
independent predictor of mortality in the final multivari-
ate model. It is also interesting to observe that the high-
est cognitive functioning individuals in our cohort had
Table 1 Participants’ baseline characteristics by quintile groups of composite cognitive scores, Selenium and Cognitive
Decline Study, People’s Republic of China, December 2003 – April 2012
Cognitive quintile groups
Quintile 1 Quintile 2 Quintile 3 Quintile 4 Quintile 5
(n = 400) (n = 400) (n = 400) (n = 400) (n = 400) p value
Mean age, years (SD) 75.3(6.1) 72.8(5.6) 71.6(5.3) 70.5(4.5) 69.5(4.3) <.0001
Female (%) 297(74.3) 240(60.0) 226(56.5) 184(46.0) 132(33.0) <.0001
Ever attended school (%) 52(13.0) 109(27.3) 145(36.3) 177(44.3) 270(67.5) <.0001
Marital status (%) <.0001
Married 198(49.5) 231(57.8) 252(63.0) 276(69.0) 294(73.5)
Widowed 201(50.3) 165(41.3) 142(35.5) 118(29.5) 100(25.0)
Other 1(0.3) 4(1.0) 6(1.5) 6(1.5) 6(1.5)
Household composition (%) <.0001
Live with spouse 152(38.0) 187(46.8) 194(48.5) 232(58.0) 248(62.0)
Live with children 158(39.5) 114(28.5) 120(30.0) 87(21.8) 66(16.5)
Live with spouse and children 22(5.5) 24(6.0) 21(5.3) 26(6.5) 28(7.0)
Other 68(17.0) 75(18.8) 65(16.3) 55(13.8) 58(14.5)
Smoking (%) 128(32.0) 155(38.8) 195(48.8) 209(52.3) 241(60.3) <.0001
Consume alcohol (%) 133(33.3) 157(39.3) 183(45.8) 180(45.0) 220(55.0) <.0001
Body mass index, kg/m2 20.9(3.2) 21.5(3.3) 21.9(3.4) 22.5(3.5) 22.9(3.8) <.0001
BMI groups:
Underweight 85(21.3) 59(14.8) 53(13.3) 36(9.0) 39(9.8) <.0001
Normal weight 274(68.5) 291(72.8) 277(69.3) 286(71.5) 257(64.3)
Overweight 37(9.3) 43(10.8) 60(15.0) 66(16.5) 88(22.0)
Obese 4(1.0) 7(1.8) 10(2.5) 12(3.0) 16(4.0)
Systolic blood pressure, mmHg (SD) 145.2(25.3) 144.0(23.4) 145.9(25.1) 147.1(24.7) 146.2(26.0) 0.4693
Diastolic blood pressure, mmHg (SD) 83.1(12.8) 83.2(12.3) 83.7(13.1) 84.2(12.3) 84.0(12.7) 0.6546
History of (%)
Cancer 0(0.0) 3(0.8) 3(0.8) 3(0.8) 4(1.0) 0.4686
Parkinson’s disease 5(1.3) 1(0.3) 4(1.0) 6(1.5) 2(0.5) 0.3062
Diabetes 10(2.5) 10(2.5) 9(2.3) 9(2.3) 14(3.5) 0.7911
Hypertension 228(57.0) 222(55.5) 235(58.8) 254(63.5) 231(57.8) 0.1936
Stroke 16(4.0) 7(1.8) 18(4.5) 10(2.5) 11(2.8) 0.1492
Heart attack 12(3.0) 8(2.0) 14(3.5) 11(2.8) 24(6.0) 0.0247
Head injury 28(7.0) 17(4.3) 29(7.3) 21(5.3) 23(5.8) 0.3465
Fracture 7(1.8) 9(2.3) 14(3.5) 9(2.3) 12(3.0) 0.5476
APOE genotype, ε4 carriers (%) 84(21.0) 66(16.5) 60(15.0) 63(15.8) 60(15.0) 0.1226
p-values in bold indicate significance at the 0.05 level.
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the other cognitive groups suggesting that the lower mor-
tality risk in the high cognition group is unlikely due to
better physical health in this group.
In terms of BMI, our results support previous findings
of increased mortality risk for underweight participants
as previously reported in a large Chinese study that also
included younger study subjects (mean age 52 years) [25],
in white adults [6], and in non-Hispanic black adults [26].The increased mortality risk in underweight individuals was
thought to be due to increased comorbidity burdens in
these individuals. However, our final multivariate models
included diabetes, stroke and cognitive function and still
found significantly increased mortality hazard for the un-
derweight participants, hence these comorbid conditions
are unlikely to account for the increased mortality in this
group. The underweight individuals were also suspected to
be suffering from terminal diseases that resulted in weight
Figure 2 Kaplan-Meier Survival Curves by Body Mass Index Groups, Selenium and Cognitive Decline Study, People’s Republic of China,
December 2003 – April 2012.
Figure 1 Kaplan-Meier Survival Curves by Cognitive Quintile Groups, Selenium and Cognitive Decline Study, People’s Republic of China,
December 2003 – April 2012.
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Table 2 Results of Multivariate Cox’s Proportional Hazard Model, Selenium and Cognitive Decline Study, People’s
Republic of China, December 2003 – April 2012
Variables Entire cohort (n = 2000) Sub-sample (n = 1948)*
Hazard ratio 95% CI Hazard ratio 95% CI
Age at Baseline 1.096 (1.080-1.113) 1.095 (1.078-1.113)
Female 0.579 (0.478-0.701) 0.542 (0.442-0.664)
BMI:
Underweight 1.639 (1.301-2.064) 1.504 (1.170-1.933)
Overweight 1.092 (0.818-1.457) 1.047 (0.770-1.424)
Obese 0.392 (0.146-1.055) 0.314 (0.100-0.984)
Normal weight 1.000 Reference 1.000 Reference
Diabetes 2.235 (1.390-3.595) 2.303 (1.391-3.814)
Stroke 1.777 (1.142-2.765) 1.954 (1.241-3.077)
Cognitive quintiles
1st Quintile 1.475 (1.130-1.926) 1.165 (0.878-1.545)
2nd Quintile 1.241 (0.936-1.645) 0.791 (0.588-1.064)
3rd Quintile 1.000 Reference 1.000 Reference
4th Quintile 1.074 (0.803-1.439) 0.851 (0.628-1.154)
5th Quintile 0.686 (0.493-0.955) 0.537 (0.380-0.759)
*Excluding individuals who died within one year of baseline evaluation.
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individuals who died within one year of baseline evaluation,
we still observed an increased mortality risk in the under-
weight individuals. In fact, the survival plot in Figure 2
seems to suggest a steady rate of death in the underweight
group across the seven years of follow-up.
While our analyses lend support to a protective effect
of cognitive reserve, our results are inconclusive on the
effect of a physiologic reserve. Unlike previous studies
[6,25,26], we did not find an increased mortality risk for
those overweight or obese. We also did not find lower
mortality among those overweight and obese partici-
pants as reported in other studies [7]. Since this cohort
has few participants with BMI in the obese range, we an-
ticipated insufficient power to examine the risk associated
with obesity. Nevertheless, the survival plot in Figure 2
and the hazard ratio estimate for the overweight group
suggest that there are little differences in mortality risk be-
tween the overweight and normal weight participants.
Thus for physiologic reserves defined by BMI, our results
support the maintenance of normal weight in the elderly,
but offer no evidence of additional protection from BMI
higher than normal weight on mortality risk.
Other predictors that have been consistently shown to
be risk factors for mortality include older age, male gen-
der, history of diabetes and cardiovascular diseases [27].
Interestingly, in our cohort education was not associated
with mortality after adjusting for cognitive function, al-
though the majority of our cohort has little or no educa-
tion (62%). The low variation in education levels amongour participants may explain the lack of association be-
tween education and mortality. Alternatively, the effect
of education may be attenuated in the presence of cogni-
tive function in the survival models.
Results on the relationship between APOE ε4 genotype
and mortality risk have not been consistent as some
studies found increased mortality risk in APOEε4 carriers
[28,29] while others reported no relationship [30,31]. The
discrepancy in results was sometimes attributed to whether
cognitive status was adjusted in the models or to low ε4
allele frequencies in the population studied [27]. In our
cohort, APOEε4 was not a significant predictor of mortal-
ity even without adjusting for cognitive function. However,
this cohort does have low APOEε4 frequency (8.8%) [13]
which may account for the non-significant relationship
between APOEε4 and mortality.
Our study has a number of strengths. The first is our
large cohort size with relatively long follow-up. A compre-
hensive set of cognitive measures were used in our study
ensuring robust results in grouping participants according
to their composite cognitive scores. The cohort is also
unique as few studies with cognitive and body composition
measures have been conducted in rural elderly Chinese.
This study also has important limitations. Our analysis
focused on all causes mortality as many of our partici-
pants died at home and accurate information on causes
of death was not available. It is also possible that other
predictors of mortality, especially socio-economic infor-
mation other than education, were not included in our
models.
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In summary, in this rural elderly Chinese cohort followed
over seven years, baseline cognitive function and BMI were
independent predictors of mortality risk. We found that
underweight participants had increased mortality risk com-
pared to participants with normal weights. In addition, we
found that individuals with high cognition had decreased
mortality risk. Our results suggest that maintaining ad-
equate BMI may be a more important priority in reducing
mortality risk in the elderly population than implement-
ing weight loss programs. Our results also indicate that
increasing cognitive reserves through education and im-
proved literacy to maintaining high cognitive function
in late life is important in reducing mortality risk.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
SG, YJ, FWU, HCH participated in the design of the study. YJ, YC, LS, FM, CC,
JL, AMH, JRM, JB and PL supervised the data collection. SG and CW
performed the statistical analysis and drafted the manuscript. All authors
read and approved the final manuscript.
Acknowledgement
This research was supported by grants from the National Institutes of Health:
R01 AG019181 and P30 AG10133.
Author details
1Department of Biostatistics, Indiana University School of Medicine, 410 West
10th Street, #3000, Indianapolis IN 46202-2872, Indiana. 2Department of
Psychiatry, Indiana University School of Medicine, Indianapolis, Indiana.
3Department of Neurology, Indiana University School of Medicine,
Indianapolis, Indiana. 4Department of Pathology and Laboratory Medicine,
Indiana University School of Medicine, Indianapolis, Indiana. 5Indiana
University Center for Aging Research, Indianapolis, Indiana. 6Regenstrief
Institute, Inc, Indianapolis, Indiana. 7Eli Lilly and Company, Indianapolis,
Indiana. 8Institute for Environmental Health and Related Product Safety,
Chinese Center for Disease Control and Prevention, Beijing, China.
9Shandong Institute for Prevention and Treatment of Endemic Disease in
China, Jinan, China. 10Sichuan Provincial Center for Disease Control and
Prevention in China, Chengdu, China.
Received: 10 September 2013 Accepted: 10 December 2013
Published: 26 March 2014
References
1. Todd S, Barr S, Roberts M, Passmore AP: Survival in dementia and predictors
of mortality: a review. Int J Geriatr Psychiatry 2013, 28(11):1109–1124.
2. Sachs GA, Carter R, Holtz LR, Smith F, Stump TE, Tu W, Callahan CM:
Cognitive impairment: an independent predictor of excess mortality: a
cohort study. Ann Intern Med 2011, 155:300–308.
3. Stump TE, Callahan CM, Hendrie HC: Cognitive impairment and mortality
in older primary care patients. J Am Geriatr Soc 2001, 49:934–940.
4. Katzman R: Education and the prevalence of dementia and Alzheimer’s
disease. Neurology 1993, 43:13–20.
5. McGee DL, Diverse Populations C: Body mass index and mortality: a
meta-analysis based on person-level data from twenty-six observational
studies. Ann Epidemiol 2005, 15:87–97.
6. Berrington de Gonzalez A, Hartge P, Cerhan JR, Flint AJ, Hannan L, MacInnis RJ,
Moore SC, Tobias GS, Anton-Culver H, Freeman LB, et al: Body-mass index
and mortality among 1.46 million white adults. N Engl J Med 2010,
363:2211–2219.
7. Flegal KM, Kit BK, Orpana H, Graubard BI: Association of all-cause mortality
with overweight and obesity using standard body mass index categories: a
systematic review and meta-analysis. JAMA 2013, 309:71–82.8. Cohen SS, Signorello LB, Cope EL, McLaughlin JK, Hargreaves MK, Zheng W,
Blot WJ: Obesity and all-cause mortality among black adults and white
adults. Am J Epidemiol 2012, 176:431–442.
9. Hughes V: The big fat truth. Nature 2013, 497:428–430.
10. Manson JE, Stampfer MJ, Hennekens CH, Willett WC: Body weight and
longevity. A reassessment. JAMA 1987, 257:353–358.
11. Emsley CL, Gao S, Hall KS, Hendrie HC: Estimating odds ratios adjusting for
misclassification in Alzheimer’s disease risk factor assessment. Stat Med
2000, 19:1523–1530.
12. Zhang ZX, Zahner GE, Roman GC, Liu J, Hong Z, Qu QM, Liu XH, Zhang XJ,
Zhou B, Wu CB, et al: Dementia subtypes in China: prevalence in Beijing,
Xian, Shanghai, and Chengdu. Arch Neurol 2005, 62:447–453.
13. Gao S, Jin Y, Hall KS, Liang C, Unverzagt FW, Ji R, Murrell JR, Cao J, Shen J,
Ma F, et al: Selenium level and cognitive function in rural elderly
Chinese. Am J Epidemiol 2007, 165:955–965.
14. Morris JC, Heyman A, Mohs RC, Hughes JP, van Belle G, Fillenbaum G,
Mellits ED, Clark C: The Consortium to Establish a Registry for Alzheimer’s
Disease (CERAD). Part I. Clinical and neuropsychological assessment of
Alzheimer’s disease. Neurology 1989, 39:1159–1165.
15. Isaacs B, Akhtar AJ: The set test: a rapid test of mental function in old
people. Age Ageing 1972, 1:222–226.
16. Hall KS, Ogunniyi AO, Hendrie HC, Osuntokun BO, Hui SL, Musick BS,
Rodenberg CA, Unverzagt FW, Guerje O, Baiyewu OA: A cross-cultural
community based study of dementias: methods and performance of the
survey instrument: Indianapolis, U.S.A. and Ibadan, Nigeria. Int J Methods
Psychiatr Res 1996, 6:129–142.
17. Yang M, Hendrie HC, Hall KS, Oluwole OS, Hodes ME, Sahota A: Improved
procedure for eluting DNA from dried blood spots. Clin Chem 1996,
42:1115–1116.
18. Hixson JE, Vernier DT: Restriction isotyping of human apolipoprotein E
by gene amplification and cleavage with HhaI. J Lipid Res 1990,
31:545–548.
19. Obesity: preventing and managing the global epidemic: report of a
WHO consultation. In Book Obesity: preventing and managing the global
epidemic: report of a WHO consultation. City; 2000:1–253. http://libdoc.who.
int/trs/WHO_TRS_894.pdf.
20. Prince M, Acosta D, Ferri CP, Guerra M, Huang Y, Llibre Rodriguez JJ, Salas A,
Sosa AL, Williams JD, Dewey ME, et al: Dementia incidence and mortality
in middle-income countries, and associations with indicators of cognitive
reserve: a 10/66 Dementia Research Group population-based cohort
study. Lancet 2012, 380:50–58.
21. Guehne U, Angermeyer MC, Riedel-Heller S: Is mortality increased in mildly
cognitively impaired individuals? A systematic literature review. Dement
Geriatr Cogn Disord 2006, 21:403–410.
22. Dewey ME, Saz P: Dementia, cognitive impairment and mortality in
persons aged 65 and over living in the community: a systematic review
of the literature. Int J Geriatr Psychiatry 2001, 16:751–761.
23. Park MH, Kwon DY, Jung JM, Han C, Jo I, Jo SA: Mini-Mental Status
Examination as predictors of mortality in the elderly. Acta Psychiatr Scand
2013, 127:298–304.
24. Langa KM, Larson EB, Karlawish JH, Cutler DM, Kabeto MU, Kim SY, Rosen AB:
Trends in the prevalence and mortality of cognitive impairment in the
United States: is there evidence of a compression of cognitive morbidity?
Alzheimers Dement 2008, 4:134–144.
25. Chen Z, Yang G, Offer A, Zhou M, Smith M, Peto R, Ge H, Yang L, Whitlock G:
Body mass index and mortality in China: a 15-year prospective study of
220 000 men. Int J Epidemiol 2012, 41:472–481.
26. Park Y, Hartge P, Moore SC, Kitahara CM, Hollenbeck AR, Berrington de
Gonzalez A: Body mass index and mortality in non-Hispanic black adults
in the NIH-AARP Diet and Health Study. PLoS One 2012, 7:e50091.
27. Gustafson DR, Mazzuco S, Ongaro F, Antuono P, Forloni G, Albani D, Gajo GB,
Durante E, Caberlotto L, Zanardo A, et al: Body mass index, cognition,
disability, APOE genotype, and mortality: the “Treviso Longeva” Study. Am J
Geriatr Psychiatry 2012, 20:594–602.
28. Little DM, Crooks VC, Petitti DB, Chiu V, Schellenberg GD, Slezak JM,
Jacobsen SJ: Mortality, dementia, and apolipoprotein E genotype in
elderly white women in the United States. J Am Geriatr Soc 2009,
57:231–236.
29. Tilvis RS, Strandberg TE, Juva K: Apolipoprotein E phenotypes, dementia
and mortality in a prospective population sample. J Am Geriatr Soc 1998,
46:712–715.
Gao et al. Archives of Public Health 2014, 72:9 Page 8 of 8
http://www.archpublichealth.com/content/72/1/930. Rosvall L, Rizzuto D, Wang HX, Winblad B, Graff C, Fratiglioni L: APOE-related
mortality: effect of dementia, cardiovascular disease and gender. Neurobiol
Aging 2009, 30:1545–1551.
31. Juva K, Verkkoniemi A, Viramo P, Polvikoski T, Kainulainen K, Kontula K,
Sulkava R: APOE epsilon4 does not predict mortality, cognitive decline, or
dementia in the oldest old. Neurology 2000, 54:412–415.
doi:10.1186/2049-3258-72-9
Cite this article as: Gao et al.: Cognitive function, body mass index and
mortality in a rural elderly Chinese cohort. Archives of Public Health
2014 72:9.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
